NCT03116113 - A Clinical Trial of Retinal Gene Therapy for X-linked Retinitis Pigmentosa Using BIIB112 | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 8, 2017

Primary Completion Date

November 18, 2020

Study Completion Date

November 18, 2020

Conditions

X-Linked Retinitis Pigmentosa

Interventions

BIOLOGICAL

BIIB112

Administered as specified in the treatment arm.

Trial Locations (8)

Research Site, Philadelphia

Research Site, Gainesville

Research Site, Miami

Research Site, Dallas

Research Site, Portland

Research Site, Manchester

Research Site, Oxford

Research Site, Southampton